Literature DB >> 329988

Chemotherapy of advanced soft-tissue sarcomas in adults.

H M Pinedo, Y Kenis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 329988     DOI： 10.1016/s0305-7372(77)80006-6

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  24 in total

1.  An effective chemotherapy regimen for liver metastasis from retroperitoneal fibrosarcoma: report of a case.

Authors:  H Isobe; Y Wada; J Ryo; T Matsushita; T Makino; B Satoh; S Kanaya; T Katayama; M Ohtoshi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 2.  Current impact of adjuvant chemotherapy in resectable cancer.

Authors:  A Rossi; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 3.  A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy.

Authors:  R Abraham; R L Basser; M D Green
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

4.  [Pre- and postoperative chemotherapy in bone and soft tissue tumors].

Authors:  K Höffken
Journal:  Langenbecks Arch Chir       Date:  1987

5.  Soft-tissue sarcomas.

Authors:  S Santavirta; S Tötterman; P Gröhn; E Heinonen; J Sandelin; B Sundell
Journal:  Br Med J       Date:  1979-10-13

6.  Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.

Authors:  N B Bui; J Chauvergne; C Hocke; M Durand; R Brunet; J M Coindre
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 7.  Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma.

Authors:  V H C Bramwell; D Anderson; M L Charette
Journal:  Cochrane Database Syst Rev       Date:  2003

8.  High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.

Authors:  R C Stuart-Harris; P G Harper; C A Parsons; S B Kaye; C A Mooney; N F Gowing; E Wiltshaw
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.

Authors:  W P Steward; J Verweij; R Somers; G Blackledge; M Clavel; A T Van Oosterom; B Greifenberg; J Soedirman; D Thomas; M Van Glabbeke
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

10.  Alternatives to CYVADIC combination therapy of soft tissue sarcomas.

Authors:  J H Hartlapp; H J Münch; H J Illiger; H Wolter; J C Jensen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.